Paragon Capital Management (Utah)’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,007
| Closed | -$669K | – | 81 |
|
|
2024
Q3 | $669K | Buy |
10,007
+4,937
| +97% | +$330K | 0.49% | 58 |
|
|
2024
Q2 | $602K | Buy |
+5,070
| New | +$602K | 0.46% | 57 |
|
|
2023
Q1 | – | Sell |
-7,228
| Closed | -$1.3M | – | 75 |
|
|
2022
Q4 | $1.3M | Sell |
7,228
-521
| -7% | -$93.6K | 1.21% | 18 |
|
|
2022
Q3 | $916K | Sell |
7,749
-1,103
| -12% | -$130K | 0.9% | 44 |
|
|
2022
Q2 | $1.26M | Sell |
8,852
-5,675
| -39% | -$811K | 1.28% | 18 |
|
|
2022
Q1 | $2.5M | Buy |
14,527
+5,205
| +56% | +$897K | 2.32% | 8 |
|
|
2021
Q4 | $2.37M | Buy |
+9,322
| New | +$2.37M | 2.02% | 11 |
|